Does sustained elevated BMI accelerate the progression of islet autoimmunity in people not yet diagnosed with diabetes?
Read More »Glycemic and Adiposity Benefits with Metformin Use in Pregnancy
A placebo-controlled trial was conducted to determine fetal, neonatal, and maternal outcomes associated with metformin use during pregnancy in women with T2DM.
Read More »Common Diabetes Medication as Treatment for Parkinson’s Disease
Findings show Parkinson’s disease risk is reduced in patients with type 2 diabetes mellitus (T2DM) after treatment with exenatide.
Read More »Brain Damage Associated with High Blood Glucose
Researchers continue to uncover the many ways uncontrolled hyperglycemia can damage the body.
Read More »Left Ventricular Mass Reduction and Empagliflozin
Empagliflozin significantly lowered LVMi, systolic blood pressure, and diastolic blood pressure in patients with CAD and type 2 diabetes.
Read More »ADA Guidelines Recommend Earlier Combination Therapy
American Diabetes Association guidelines recommend that combination therapy be started in patients with unachieved glycemic control within three months.
Read More »Using Electromagnetic Fields to Treat Diabetes
Researchers say static electromagnetic fields (EMFs) could be a non-invasive and safe way of managing blood glucose.
Read More »Diabetes in Your Pet May Increase Your Risk
A recent cohort study offers more insight into whether cat and dog owners and their pets share a risk of acquiring type 2 diabetes.
Read More »Down Syndrome Youth Have a High Prevalence of Dyslipidemia and Prediabetes
Two-thirds of youth with Down syndrome have a BMI percentile at or above 85, but is this a marker for prediabetes and dyslipidemia in this population?
Read More »New Study Finds Loneliness A Risk Factor for Type 2 Diabetes
Loneliness may increase risk for type 2 diabetes, even in patients who are not socially isolated.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.